Related Experiment Video

Updated: Jan 23, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

882

Oncogenic NRG1 Fusions: A New Hope for Targeted Therapy in Pancreatic Cancer

Andrew J Aguirre1,2

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. andrew_aguirre@dfci.harvard.edu.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|June 6, 2019
PubMed

Insights

Approximately 8%-10% of pancreatic cancers lack KRAS mutations. In these cases, NRG1 gene fusions are targetable drivers, offering a new treatment strategy. Deep molecular profiling is crucial for identifying these actionable alterations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a lethal malignancy.
  • Most PDAC cases harbor KRAS mutations, limiting targeted therapy options.
  • A subset of PDAC is KRAS wild type, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To investigate the role of gene fusions in KRAS wild-type PDAC.
  • To identify targetable oncogenic drivers in this specific PDAC subset.
  • To highlight the clinical significance of comprehensive molecular characterization.

Main Methods:

  • Analysis of tumor samples from patients with KRAS wild-type PDAC.
  • Next-generation sequencing (NGS) for detecting gene fusions.
  • Identification of NRG1 gene fusions as potential therapeutic targets.

Main Results:

  • NRG1 gene fusions were identified in a subset of KRAS wild-type PDAC.
  • These NRG1 fusions represent targetable oncogenic drivers.
  • This finding underscores the importance of molecular profiling.

Conclusions:

  • NRG1 gene fusions are actionable targets in a subset of KRAS wild-type PDAC.
  • Deep molecular characterization is essential for identifying novel treatment strategies.
  • Targeting NRG1 fusions offers a promising therapeutic avenue for specific PDAC patients.

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

12.3K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.2K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Nuclear Fusion02:45

Nuclear Fusion

The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.7K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.4K
Tagging and Fusion Proteins01:24

Tagging and Fusion Proteins

Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.4K